
Keywords: فاکتور رونویسی هومیوودینام 2 مانند; action potentials; antagomirs; gene therapy; genetic loci; genetic predisposition to disease; microRNAs; AF; atrial fibrillation; APD; action potential duration; CHF; congestive heart failure; DNA; deoxyribonucleic acid; GWAS; genome-wide association stud